why choose us

First received: March 01, 2023

Clinical Trial: RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: RecoverPC: A Phase 2 Study of RElugolix Versus GnRH Agonist Quality of Life (QOL) and Testosterone reCOVERy in Men With Prostate Cancer

Brief Summary: This study is testing the way that approved androgen deprivation therapy treatments, Leuprolide and Relugolix, for prostate cancer affect quality of life, blood levels, cholesterol, and blood sugar.The drugs are already standard treatment for people with prostate cancer, and the drugs will be used as described in their label.The names of the study drugs involved in this study are:Leuprolide (type of ADT)Relugolix (type of ADT)

Read more